The study, published Aug. 27 in The Lancet, enrolled 822 patients between January 2018 and December 2022, and assigned them to a cardiac arrest center or to standard care following an out-of-hospital cardiac arrest without ST elevation.
During the study, 30-day mortality occurred in 63 percent of patients in both groups, and 2 percent of patients at the arrest center had serious adverse events compared to 1 percent of the standard care group. None of the adverse events were deemed related to the trial intervention.
The study concluded that transferring patients to a cardiac arrest center following resuscitated cardiac arrest did not reduce deaths.
Leave a Reply